(Q37715006)

22 August 2017

1 reference

title

Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS. (English)

1 reference

22 August 2017

0 references

1 reference

Maria Rosa Gasco

1

1 reference

22 August 2017

Lorenzo Priano

series ordinal

2

1 reference

22 August 2017

Gian Paolo Zara

series ordinal

3

1 reference

22 August 2017

publication date

8 December 2009

1 reference

Progress in Brain Research

22 August 2017

published in

1 reference

22 August 2017

volume

180

1 reference

22 August 2017

page(s)

181-192

1 reference

Astrocyte-endothelial interactions and blood-brain barrier permeability

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Role of the CNS microvascular pericyte in the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Preparation and characterization of solid lipid nanospheres containing paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Blood-brain barrier permeability to small and large molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

A benefit-risk assessment of baclofen in severe spinal spasticity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Drug targeting to the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

The absolute bioavailability of oral melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Absorption of apomorphine by various routes in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Tight junctions of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

In situ blood-brain barrier transport of nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

The molecular structure of the tight junction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

The critical component to establish in vitro BBB model: Pericyte

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Brain uptake of thiamine-coated nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Assessing sedation with regional anesthesia: inter-rater agreement on a modified Wilson sedation scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Transdermal permeation of apomorphine through hairless mouse skin from microemulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

The human H and T reflex methodologies applied to the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

The choroid plexuses and the barriers between the blood and the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

P-Glycoprotein, a gatekeeper in the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Progress in understanding the structure-activity relationships of P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Body distribution of camptothecin solid lipid nanoparticles after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

CNS drug design based on principles of blood-brain barrier transport

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2980010-6

7 January 2021

10.1016/S0079-6123(08)80010-6

Identifiers

DOI

1 reference

22 August 2017

1 reference